Top Markets
#1 0G 0G +23.70%
#2 Axelar Axelar +21.97%
#3 Cysic Cysic +21.57%
#4 Zora Zora +21.03%
#5 SAFEcoin SAFEcoin +19.60%
#6 Full Moon Full Moon +18.95%
#7 StonkBroker StonkBroker +16.85%
#8 AI XOVIA AI XOVIA +16.64%
#9 Merlin's Seal BTC Merlin's Seal BTC +16.61%
#10 ADO Protocol ADO Protocol +15.25%
Coin of the day
0G 0G
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Graphite Bio, Inc. Graphite Bio, Inc.

Graphite Bio, Inc.

GRPH
Classifica tra le azioni #12750
Graphite Bio, Inc. is a clinical-stage gene editing company dedicated to... Graphite Bio, Inc. is a clinical-stage gene editing company dedicated to developing innovative therapeutic solutions for severe and life-threatening illnesses across the United States. Its primary investigational therapy, GPH101, is an autologous, gene-edited hematopoietic stem cell product specifically engineered to directly correct the underlying mutation causing sickle cell disease, thereby restoring normal adult hemoglobin production. The company's pipeline also features GPH201, intended for the treatment of X-linked severe combined immunodeficiency syndrome, and GPH301, an experimental candidate designed to address Gaucher disease, a genetic disorder characterized by a deficiency in the glucocerebrosidase enzyme. Initially established as Integral Medicines, Inc., the company rebranded to Graphite Bio, Inc. in August 2020. Founded in 2017, Graphite Bio's operations are based out of its headquarters in South San Francisco, California.
Prezzo delle azioni
$22.26
Ultima sincronizzazione: 2024-03-22
Capitalizzazione di mercato
$553.40M
Variazione (1 giorno)
0.00%
Variazione (1 anno)
0.00%
Paese
US
Scambia Graphite Bio, Inc. (GRPH)

Categoria

Healthcare
Storico del prezzo dell'azione per Graphite Bio, Inc. (GRPH)
Prezzo di chiusura più alto: $23.07 il 2024-03-01

Prezzo di chiusura più basso: $174.18 il 2021-06-01
Storico del prezzo dell'azione di Graphite Bio, Inc. dal 2021 al 2026
Andamento annuale del prezzo dell'azione
Anno Performance
2024 40.75%
2023 -26.18%
2022 -70.69%
2021 0.00%
Prezzo dell'azione per aziende simili o concorrenti
Azienda Prezzo dell'azione Variazione 1a% Il paese
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $542.09 38.63%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.03K 44.13%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $121.01 -13.08%
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $138.18 473.58%
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $750.94 6.02%
CH